Studies found that taking 14 mg of oral semaglutide daily lowered A1C by 1.2% after 26 weeks
Quick answer: when GLP 1 therapy is and is not the right tool GLP 1 therapy can be a strong option when menopause weight gain is tied to insulin resistance, appetite dysregulation, visceral fat gain, or repeated plateaus despite consistent habits
Consumers should be particularly wary of injectable preparations on sale in cosmetic studios, beauty salons or similar outlets because in many cases the products in question are illegal
Less common reports include fatigue 1224 hours after dosing, injection-site redness, and brief flushing
Ingredient qualification, testing, documentation, and controls designed to provide confidence from raw material through finished product